González SA, Amaya GM

Language: Spanish
References: 14
Page: 103-107
PDF size: 154.59 Kb.

ABSTRACT

Background: psoriasis is a chronic disease that affects approximately 2% of world’s population a relationship between this and cardiovascular risk has been established. However, the possibility of psoriasis as an independent cardiovascular risk factor has been propound.
Methodology and material: retrospective analytic studies of cases and controls. Patients older than 30 years who were diagnosed with psoriasis, between October 1st 2011 and September 30th 2012. Inferential statistics Student’s T test was used for quantitative variables and squared Chi for qualitative variables. Risk factors were analyzed through odds ratio in the bivariate analysis. With p<0.05 as significance.
Results: 120 patients were included, 40 cases and 80 controls. Patients were arranged by age and gender. For cases σ = 48 ± 18 while for controls σ = 46 ± 16, with a significance of p 0.522. Regarding the cardiovascular incidents (cases) 28 males and 12 females (ami) and controls (56 males, 24 females) or 1.0 and ci = 0.43–2.28.
Conclusions: psoriasis is not a direct risk factor to develop cardiovascular events.

REFERENCES

1. Gisondi, P. et al., “Metabolic comorbidities and Psoriasis”, Acta Dermatovenerol Croat, 2010, 18 (4): 297-304.

2. Anselmi, C.L., Galimberti, M.L., De Luca, D.A. et al., “Psoriasis: prevalencia de comorbilidades cardiovasculares en la población del Plan de Salud del Hospital Italiano de Buenos Aires. Estudio de corte, 2010”, Dermatol. Argent., 2012, 18 (3): 239-244.

3. Ríos Yuil, J.M., Yuil de Ríos, E., “Psoriasis y enfermedad cardiovascular: mecanismos inmunológicos y moleculares”, Rev. Med. Cient., 2011, 24 (1): 33-41.

4. Choi, W.J., Park, E.J., Kwon, I.H. et al., “Association between psoriasis and cardiovascular risk factors in Korean patients”, Ann Dermatol, 2010, 22 (3): 300-306.

5. Cohen, A.D., Weitzman, D., Dreiher, J. et al., “Psoriasis and hypertension: a case-control study, Acta Derm. Venereol., 2010, 90: 23-26.

6. Arican, O., Aral, M. et al., “Serum levels of tnf-alpha, ifn-y, il-6, il-8, il-12, il-17, and il-18 in Patients with active Psoriasis and Correlation with Disease Severity”, Mediators inflamm., 2005 (5): 273-279.

7. Ghazizadeh, R., Shimizu, H., Tosa, M., Ghazizadeh, M., “Pathogenic mechanisms shared between psoriasis and cardiovascular disease”, Int J Med Sci, 2010, 7 (5): 284-289.

8. Setty, A.R., Curhan, G., Choi, H.K., “Obesity, waist circumference, weight change and the risk of psoriasis in women: Nurses Health Study II”, Arch Intern Med., 2007, 167 (15): 1670-1675.

9. Fernández, T.R., Pita, F.S., Fonseca, E., “Psoriasis and cardiovascular risk. Assessement by different cardiovascular risk scores”, J Eur Acad Dermatol Venereol, 2012, 27 (12), 1566-1570.

10. Farías, M.M., Serrano, V., De la Cruz, C., “Psoriasis y obesidad: revisión y recomendaciones prácticas”, Actas Dermosifiliogr, 2011, 102: 505-509.

11. Gisondi, P., Farina, S., Vittoria, M. et al., “Usefulness of the Framingham Risk Score in Patients with Chronic Psoriasis”, Am J Cardiol, 2010, 106: 1754-1757.

12. González, M.A., González, C. et al., “Psoriasis: A skin Disease Associated With Increased Cardiovascular Risk”, Actas Dermosifiliogr, 2012, 103 (7): 595-598.

13. Sidiropoulos, P., Karvounaris, S., Boumpas, D. et al., “Metabolic syndrome in rheumatic diseases: epidemiology, pathophysiology and clinical implications”, Arthritis Res Ther, 2008, 10: 207.

14. Rizvia, A., “Inflammation markers as mediators of vasculo-endothelial dysfunction and atherosclerosis in the metabolic syndrome and type 2 diabetes”, Chin Med J, 2007, (120): 1918-1924.